{"disease":{"id":"non-small-cell-lung-cancer-nsclc-with-high-pd-l1-expression-50-as-a-monotherapy-in-adults-and-in-combination-with-pembrolizumab-in-adults.md","name":"non small cell lung cancer nsclc with high pd l1 expression 50 as a monotherapy in adults and in combination with pembrolizumab in adults.md"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[],"total":0},"guidelines":[],"source":"Drug Landscape verified database"}